These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 37727166)

  • 1. A Comprehensive Literature Review on Managing Systemic Lupus Erythematosus: Addressing Cardiovascular Disease Risk in Females and Its Autoimmune Disease Associations.
    Dar S; Koirala S; Khan A; Bellary MD; Patel AV; Mathew B; Singh R; Baigam N; Razzaq W; Abdin ZU; Khawaja UA
    Cureus; 2023 Aug; 15(8):e43725. PubMed ID: 37727166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for cardiovascular diseases in patients with systemic lupus erythematosus: an umbrella review.
    Katayama Y; Yanai R; Itaya T; Nagamine Y; Tanigawa K; Miyawaki Y
    Clin Rheumatol; 2023 Nov; 42(11):2931-2941. PubMed ID: 37142864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Lupus Erythematosus and Secondary Antiphospholipid Syndrome after Thymectomy for Myasthenia Gravis - A Case Report.
    Miskovic R; Plavsic A; Peric-Popadic A; Raskovic S; Bogic M
    Open Access Maced J Med Sci; 2015 Sep; 3(3):439-42. PubMed ID: 27275267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymectomy and systemic lupus erythematosus (SLE).
    Panarese A; D'Andrea V; Pironi D; Filippini A
    Ann Ital Chir; 2014; 85(6):617-8. PubMed ID: 25919914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and clinical predictors in pregnant women with antiphospholipid syndrome and systemic lupus erythematosus: comprehensive update.
    Li X; Shopit A; Wang J
    Arch Gynecol Obstet; 2021 Nov; 304(5):1153-1160. PubMed ID: 34390384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing the unspoken: sexual dysfunction in men with systemic lupus erythematosus, a call to action for rheumatologists.
    Carrillo A; Marengo-Rodríguez D; Ibarra-Velasco-Siles M; Chávez-Barajas MJ; Barrera-Vargas A; Pérez-García LF; Merayo-Chalico J
    Sex Med Rev; 2024 Jun; 12(3):434-441. PubMed ID: 38796305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.
    Perez-Sanchez C; Barbarroja N; Messineo S; Ruiz-Limon P; Rodriguez-Ariza A; Jimenez-Gomez Y; Khamashta MA; Collantes-Estevez E; Cuadrado MJ; Aguirre MA; Lopez-Pedrera C
    Ann Rheum Dis; 2015 Jul; 74(7):1441-9. PubMed ID: 24618261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome.
    Drosos GC; Vedder D; Houben E; Boekel L; Atzeni F; Badreh S; Boumpas DT; Brodin N; Bruce IN; González-Gay MÁ; Jacobsen S; Kerekes G; Marchiori F; Mukhtyar C; Ramos-Casals M; Sattar N; Schreiber K; Sciascia S; Svenungsson E; Szekanecz Z; Tausche AK; Tyndall A; van Halm V; Voskuyl A; Macfarlane GJ; Ward MM; Nurmohamed MT; Tektonidou MG
    Ann Rheum Dis; 2022 Jun; 81(6):768-779. PubMed ID: 35110331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of placental lesions in patients with systemic lupus erythematosus, antiphospholipid syndrome and non-criteria obstetric antiphospholipid syndrome and adverse perinatal outcomes.
    Castellanos Gutierrez AS; Figueras F; Espinosa G; Youssef L; Crispi F; Santana M; Nadal A; Baños N
    Placenta; 2023 Aug; 139():92-98. PubMed ID: 37354691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Antiphospholipid Syndrome and/or Systemic Lupus Erythematosus on the Long-term Adverse Cardiovascular Outcomes in Patients After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis.
    Bundhun PK; Boodhoo KD; Long MY; Chen MH
    Medicine (Baltimore); 2016 Mar; 95(12):e3200. PubMed ID: 27015221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality.
    Riancho-Zarrabeitia L; Martínez-Taboada V; Rúa-Figueroa I; Alonso F; Galindo-Izquierdo M; Ovalles J; Olivé-Marqués A; Fernández-Nebro A; Calvo-Alén J; Menor-Almagro R; Tomero-Muriel E; Uriarte-Isacelaya E; Botenau A; Andres M; Freire-González M; Santos Soler G; Ruiz-Lucea E; Ibáñez-Barceló M; Castellví I; Galisteo C; Quevedo Vila V; Raya E; Narváez-García J; Expósito L; Hernández-Beriaín JA; Horcada L; Aurrecoechea E; Pego-Reigosa JM
    Lupus; 2020 Oct; 29(12):1556-1565. PubMed ID: 32807021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modern Management of Pregnancy in Systemic Lupus Erythematosus: From Prenatal Counseling to Postpartum Support.
    Gamba A; Zen M; Depascale R; Calligaro A; Gatto M; Iaccarino L; Doria A
    J Clin Med; 2024 Jun; 13(12):. PubMed ID: 38929983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome.
    Deák M; Bocskai M; Burcsár S; Dányi O; Fekete Z; Kovács L
    Lupus; 2014 Aug; 23(9):913-8. PubMed ID: 24729279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced circulating Tregs and positive pANCA were robustly associated with the occurrence of antiphospholipid syndrome in patients with systemic lupus erythematosus.
    Wang J; Guo HX; Cheng T; Shi L; Zhang SX; Li XF
    Lupus; 2023 May; 32(6):746-755. PubMed ID: 37051771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of a multidisciplinary clinical pathway for women with systemic lupus erythematosus and/or antiphospholipid syndrome.
    Wind M; Hendriks M; van Brussel BTJ; Eikenboom J; Allaart CF; Lamb HJ; Siebelink HJ; Ninaber MK; van Geloven N; van Lith JMM; Huizinga TWJ; Rabelink TJ; Sueters M; Teng YKO
    Lupus Sci Med; 2021 May; 8(1):. PubMed ID: 33952625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological therapy in systemic lupus erythematosus, antiphospholipid syndrome, and Sjögren's syndrome: evidence- and practice-based guidance.
    Marinho A; Delgado Alves J; Fortuna J; Faria R; Almeida I; Alves G; Araújo Correia J; Campar A; Brandão M; Crespo J; Marado D; Matos-Costa J; Oliveira S; Salvador F; Santos L; Silva F; Fernandes M; Vasconcelos C
    Front Immunol; 2023; 14():1117699. PubMed ID: 37138867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
    Sarzi-Puttini P; Atzeni F; Carrabba M
    Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and pattern of antiphospholipid antibody syndrome in a hospital based longitudinal study of 193 patients of systemic lupus erythematosus.
    Singh NK; Agrawal A; Singh MN; Kumar V; Godhra M; Gupta A; Yadav DP; Usha ; Singh RG; Singh TB
    J Assoc Physicians India; 2013 Sep; 61(9):623-6. PubMed ID: 24772699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematological disorders in patients with systemic lupus erythematosus.
    Bashal F
    Open Rheumatol J; 2013; 7():87-95. PubMed ID: 24198852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.